TMCnet News
DNA Sequencing: Emerging Technologies and ApplicationsLONDON, Sept. 5, 2016 /PRNewswire/ -- This BCC Research report provides a comprehensive discussion of sequencing technologies, market applications, industry structure, important clinical sequencing initiatives, global markets, and companies. Sales forecasts are provided from 2015 through 2020. Sequencing market segments that provide strong growth opportunities include benchtop and handheld sequencing instruments; clinical diagnostics (e.g., oncology, transplant, reproductive health); and applied sequencing services (e.g., agriculture, consumer, forensics). The report provides a comprehensive discussion of sequencing technologies, market applications, industry structure, important clinical sequencing initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for accessing sequencing industry opportunities. REASONS FOR DOING THE STUDY The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome. The HGP led to significant improvements in the efficiency and costs of DNA sequencing. During this time period, the sequencing industry consolidated, resulting in one dominant company, Applied Biosystems (now Life Technologies). Beginning in 2005, the launch of next-generation sequencing technologies radically changed the structure of the industry and opened up exciting new market applications. The costs of sequencing have rapidly dropped to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests. As a result, opportunities for sequencing products and services are emerging in diverse applications ranging, for example, from clinical diagnostics to agriculture genetic testing markets. The clinical value of sequencing has been shown for many applications, and several launched tests are having commercial success. This shows that both patients and physicians are recognizing the value of NGS tests. New product formats, including liquid biopsy and single cell sequencing, are being introduced. At the same time, payors and insurance companies are beginning to provide coverage for these tests, further enhancing their commercial potential. The continuing emphasis in the industry on precision medicine is helping to pave the way for sequencing systems. Examples of this include the Precision Medicine Program in the U.S., which will sequence more than one million people to identify genomic drivers of cancer, and the recent declaration of precision medicine as a focus for China's 13 Five Year Plan for 2016 to 2020. These technical and market factors are driving this market, so that it is now timely to re-examine the sequencing markets with this updated report. Download the full report: https://www.reportbuyer.com/product/254559/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dna-sequencing-emerging-technologies-and-applications-300322588.html SOURCE ReportBuyer 
|